Financial Year |
March 31 2023 |
Monetary Funds |
1,405,797,613.38 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
498,501,314.90 |
Accounts Receivable |
3,456,084,224.64 |
Advances to Suppliers |
589,856,617.69 |
Other Receivables |
2,123,850,047.54 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
648,318,853.10 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
282,657,770.97 |
Total Current Assets |
9,054,777,001.00 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
217,337,372.43 |
Long-term Equity Investment |
2,264,891,684.73 |
Investment Properties |
305,984,476.39 |
Fixed Assetes |
29,448,789,232.47 |
Under-construction Projects |
1,817,832,612.53 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
50,560,364,670.88 |
R&D expenses |
-- |
Goodwill |
4,580,366,189.16 |
Long-Term Deferred and Prepaid Expenses |
599,777,793.21 |
Deferred Income Tax Assets |
611,836,433.05 |
Other Non-Current Assets |
1,322,766,140.75 |
Sub-Total of Non-Current Assets |
94,414,292,492.90 |
Total Assets |
103,469,069,493.90 |
Short-Term Loans |
2,914,294,993.63 |
Trading Financial liabilities |
-- |
Notes Payable |
173,165,940.72 |
Accounts Payable |
5,422,547,992.46 |
Accounts Received In Advance |
798,142.20 |
Employee Compensation Payable |
141,317,243.14 |
Taxes Payable |
677,221,497.03 |
Interest Payable |
57,074,706.47 |
Dividend Payable |
-- |
Other payables |
4,365,414,070.35 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
6,406,527,019.57 |
Other Current Liabilities |
174,445,608.65 |
Sub-Total of Current Liabilities |
20,793,005,232.30 |
Long-term Loans |
16,564,137,069.59 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
17,097,122,399.60 |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
912,132,133.30 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
34,626,794,129.62 |
Total Liabilities |
55,419,799,361.92 |
Paid-In Capital(Or Share Stock) |
22,217,764,145.00 |
Capital Surplus |
13,185,435,071.90 |
Surplus Reserve |
1,177,440,581.65 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
9,504,727,021.93 |
Minority Stockholder's Interest |
3,563,179,535.54 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
44,486,090,596.44 |
Owner's Equity(Stockholder's Equity) |
48,049,270,131.98 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
103,469,069,493.90 |